Eptifibatide Acetate
Eptifibatide is an antiplatelet drug that reversibly binds and inhibits glycoprotein IIb/IIIa receptor of platelets. A protein found in the venom of a southeastern pygmy rattlesnake is used to make eptifibatide.
FDA approved eptifibatide for the medical management of unstable angina (UA) and non-ST elevation myocardial infarction (NSTEMI). In the PURSUIT trial, the eptifibatide showed favorable outcomes in reducing the composite end-point mortality and prevented nonfatal myocardial infarction in patients with non-ST elevation myocardial infarction and unstable angina.
Cas number: 881997-86-02
Sequence: Cyclo (1-7) Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2
Molecular Formula: C₃₅H₄₉N₁₁O₉S₂
Molecular weight: 831.96 a.m.u
